How Equity Crowdfunding Can Help Life Sciences Companies
There are only two weeks left to register for the webinar with Scott Jordan from Scott Jordan Associates on February 26th for an exciting presentation on Crowdfunding for Life Science Companies.
The past five years have been one of the more challenging periods for raising capital in the biotechnology industry, especially for early-stage companies. Numerous factors, including a challenging FDA environment upon NDA submission, long timelines to approval and the high rate of drug failure, have contributed to a dim venture capitalist view of the sector's prospects. As a result, emerging growth biotechnology companies are increasingly pursuing alternative financing vehicles, including Equity Crowdfunding, to advance their drug development programs.
In this ShareVault webinar, Scott will describe the different platforms available to Life Science companies including Equity and Non-Equity/"Compassionate Use" Crowdfunding. Scott will also review the JOBS Act and its provision for Equity Crowdfunding. Finally, Scott will assess the value of Equity Crowdfunding for Life Science companies including Seed, Bridge and Side Car financings. Don't miss this opportunity!
